Jupiter Neurosciences, Inc. announced on August 26, 2025, a pivotal expansion of its dual-path business model with the launch of its dedicated Nugevia™ e-commerce website, www.nugevia.com. The company also opened pre-orders for its groundbreaking longevity supplements.
This move targets the multi-trillion dollar longevity market, providing a direct-to-consumer channel for its science-based health solutions. The Nugevia™ product line is built on Jupiter’s proprietary JOTROL™ platform.
The launch of the website and pre-orders are critical steps in generating near-term revenue. This revenue stream is intended to support ongoing clinical development and corporate operating costs, enhancing long-term shareholder value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.